retatrutide type 2 diabetes phase 2 lancet 2023 rosenstock 🚨Breaking: Retatrutide's first 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending Phase 2 Trial of Retatrutide

Supplementary Information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material

The gap in efficacy between Tirzepatide and Retatrutide, approximately 3-4 percentage points of body weight at comparable doses, is real but smaller than the gap between Semaglutide and Tirzepatide

How much capacity do I need

Rising integration of digital health tools and AI for patient monitoring, adherence tracking, and outcome optimization

Additionally, if protein intake is increased without increasing physical activity, too many calories without expending enough could result in weight gain

Instead, they show how your individual biology may engage with growth factor pathways and metabolic regulation